Immutep Revenue

In the fiscal year ending June 30, 2024, Immutep had annual revenue of 3.84M AUD with 9.59% growth. Immutep had revenue of 1.73M in the half year ending June 30, 2024, a decrease of -34.22%.

Revenue

3.84M

Revenue Growth

+9.59%

P/S Ratio

100.06

Revenue / Employee

123.93K

Employees

Market Cap

465.79M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	3.84M	336.16K	9.59%
Jun 30, 2023	3.51M	-1.21M	-25.64%
Jun 30, 2022	4.71M	851.56K	22.04%
Jun 30, 2021	3.86M	-9.88M	-71.88%
Jun 30, 2020	13.74M	8.10M	143.72%
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro
Jun 30, 2016	Pro	Pro	Pro
Jun 30, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CSL Limited	22.18B
Pro Medicus	161.50M
Cochlear	2.24B
Sonic Healthcare	8.97B
Telix Pharmaceuticals	645.68M
Ramsay Health Care	16.66B
Ansell	2.43B
Sigma Healthcare	3.48B

Revenue Rankings

Immutep News

4 weeks ago - Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - GlobeNewsWire
5 weeks ago - Immutep Reports Promising New Data in Head and Neck Cancer at ESMO Immuno-Oncology 2024 - GlobeNewsWire
2 months ago - Immutep: Potential Of Efti As New Standard Of Care For NSCLC Patients - Seeking Alpha
2 months ago - Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial - Benzinga
2 months ago - Immutep's Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer - GlobeNewsWire
2 months ago - Immutep Quarterly Activities Report Q1 FY25 - GlobeNewsWire
3 months ago - Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
3 months ago - Immutep: Navigating The Bumps In The Road - Seeking Alpha

More News